Mr. Zhan has over 21 years of experience in the medical device industry. He started his career in endovascular with Cordis, Johnson & Johnson China in 1999. He took on various sales management roles of increasing responsibilities in endovascular, cardiology and electrophysiology becoming the National Sales Manager for the Biosense Webster business in 2006, where he was instrumental in building a dominant market presence with 80% market share in the AFib area. He became the Business Unit Head for St Jude’s EP business in 2009. In 2010, He joined Lifetech Scientific (01302.HK) as Chief Marketing Officer, responsible for Lifetech’s global sales and marketing. During his tenure with Lifetech, he was one of senior executives who had taken Lifetech public on the Hong Kong Stock Exchange.
Mr. Cornell is an executive with over 25 years of experience in the medical device industry. Primary focus has been new therapy development focused on innovative treatments for lung disease. He has held numerous sales and marketing management positions at Abbott Vascular, Boston Scientific Corporation and United States Surgical Corporation. The last 15 years of Mr. Cornell’s career have been spent working in the Pulmonary space with start-up companies focused on the development and commercialization of a non-invasive treatment for emphysema. In this time, Mr. Cornell has set up a global sales channel for the commercialization of this technology, focused on developing a referral network for the treatment of the disease, assisted in the execution and completion of numerous clinical studies and hired and managed a direct sales force in 8 countries.
Mr. Tang is a financial expert with over 17 years of experience at multinational corporations which including 9 years management role in biopharma and medical device industry. He has rich experience of finance management positions at Robert Bosch, BASF and Boehringer-Ingelheim in recent 10 years. He has many areas of expertise include financial planning & analysis, product costing, management reporting, profitability & business analysis, process design and improvement, internal control & compliance, ERP system implementation both in leader & consultant role, transfer pricing & local tax (China), accounting function covers AR/AP/GL/Treasury, CAPEX planning. He was an important business contributor in Asia Pacific region during his career in BASF.
Mr. Xu Joined Broncus in 2018 and worked in medical device industry for more than 10 years. Prior to Broncus, Mr. Xu served as the director of R&D at APT medical Inc. an electrophysiological catheters (EP) company providing cardiac mapping, ablation and 3D mapping system. Mr. Xu has designed several successful products into clinical trial or market such as the floating catheter, RDN ablation system, 3D mapping and ablation system.
Mr. Keast has been with Broncus since 1998 and has been a leader and contributor to nearly all products developed at Broncus as served as Principal R&D Engineer, Senior R&D Engineer and R&D Engineer. Prior to Broncus, Mr. Keast served as a Design Engineer at Stryker Endoscopy, designing and developing laparoscopic instruments such as the StrykeFlow 2, Suction Irrigator. Mr. Keast holds a B.S. in Mechanical Engineering from California Polytechnic State University in San Luis Obispo, CA.
Responsible for the operation of Broncus Hangzhou since year 2017, with over 25 years of manufacturing experience, include over 17years experience in medical industry. Prior to Broncus, Mr. Liu served as the head of qualify department of Lifetech Scientific (01302.HK), Tyco Electronics (Dongguan), AccessPoint Medical HK, Avail Medical (Shenzhen) and Neich Medical (Shenzhen). Before joining the medical device industry, Mr. Liu served as process engineer at DuPont China Tynex (Shenzhen) filaments factory, responsible for safety, process development, production, quality and maintenance managements.
Mr. Markle came to Broncus in 2017 after holding several senior level roles at GE Healthcare and Merit Medical Endotek over the course of his 25 years in healthcare. Mr. Markle started his career at OEC Medical Systems, which was acquired by GE Healthcare in 1999, as a 20 year old working on a shipping dock. Over the course of an 18 year career he was promoted multiple times holding a wide range of commercial roles including sales, sales operations, product management and clinical management in both a US and International capacity. During his 7 years at Merit Medical Endotek, Mr. Markle lead global marketing and clinical training and successfully re-positioned the company from a non-vascular stent company to an endoscopy company focusing on both GI and pulmonary markets. During his tenure at Merit Medical, Mr. Markle successfully directed growth from $6M in annual review to well over $35M. Mr. Markle holds a B.S. in International Relations and Business Administration from the University of Utah and an MBA from Westminster College.
Mr. Li has been focusing on market penetration, education and development in medical industry. Having 14 years’ experience in managing business in global market, Mr. Li has been focused on interventional treatment technologies for cardiovascular and pulmonary diseases. Currently, Mr. Li is in charge of sales, marketing and clinical education team in Asia in Broncus.